Gene Therapy Market Outlook to 2025 - Spark Therapeutics, Solid Biosciences, bluebird bio, Sangamo Therapeutics, Inc., RENOVA THERAPEUTICS, and HORAMA S.A.
The report aims to provide an overview of global gene therapy market with detailed market segmentation by cell type, application, and geography. The global gene therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
Get Sample PDF Copy of Gene Therapy Market Report http://bit.ly/2OZf6bD
The growth of the gene therapy market is regulated due to various reason which includes the rapid involvement of synthetically modified gene to treat various diseases, it helps in designing the personalized medicine, rise in the research and development of the gene therapy among the others. The gene therapy requires less doses of medicines and is one time treatment, this factor is likely to show growth opportunity for gene therapy market in coming near future.
Profiles of Key Gene Therapy Manufacturing Companies
1. Sangamo Therapeutics, Inc.
2. bluebird bio, Inc.
3. uniQure N.V.
4. AveXis, Inc.
6. Solid Biosciences.
7. Spark Therapeutics, Inc.
8. CHIMERON BIO
9. RENOVA THERAPEUTICS
10. HORAMA S.A.
Gene therapy is introduction of DNA into a patient to treat a genetic disease or a disorder. The newly inserted DNA contains a correcting gene to correct the effects of disease causing mutations. Gene therapy is promising treatment for the genetic diseases and also includes cystic fibrosis and muscular dystrophy. Gene therapy is suitable treatment for the infectious diseases, inherited disease and cancer.
The gene therapy market is segmented based on type as, somatic gene therapy and germline gene therapy. The application segment is classified as genetic disorder, cancer, neurological disorder and others. The cancer segment is expected to grow in coming years as the need of gene correction is must as the gene corrector is introduced to produce a another gene or to inhibit the expression of another gene or to disturb the activity of another gene.
North America is anticipated to dominate the gene therapy market in the global scenario owing to various factors such as reimbursement services, technological developments in the biotechnology industry and increasing research activities. Europe is the second largest market for the gene therapy as the various innovation are being done in this region. In 2016, European Union approved Zalmoxis for the treatment of leukemia. Asia Pacific is the fastest growing region as the studies are taking rapid pace for the biotechnological industry and increase in cardiovascular disease.. Owing to these factors the market are likely to propel the growth of the market for gene therapy market in coming future.
Buy the complete report with Comprehensive table of contents @ http://bit.ly/2qgIFq1
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, and Telecommunication industries.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Therapy Market Outlook to 2025 - Spark Therapeutics, Solid Biosciences, bluebird bio, Sangamo Therapeutics, Inc., RENOVA THERAPEUTICS, and HORAMA S.A. here
News-ID: 1334627 • Views: 1265
More Releases from The Insight Partners
Automated Material Handling Equipment Market Research Report by TIP
Automated Material Handling Equipment Market Research Report estimates the size of the market for 2020 and projects its growth by 2025. Automated Material Handling Equipment Market report covers the current and previous market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period. It depends on the type, the field of application and the main regions that contribute to market development. Global Automated Material
Automated Test Equipment Market Growth and Forecast Research 2025
Automated Test Equipment Market Research Report estimates the size of the market for 2020 and projects its growth by 2025. Automated Test Equipment Market report covers the current and previous market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period. It depends on the type, the field of application and the main regions that contribute to market development. The automated test equipment market
Atopic Dermatitis Drugs Market Size, Emerging Trends, Challenges and Analysis by …
Atopic Dermatitis Drugs Market - Pin-point Analysis of Market Dynamics The "Global Atopic Dermatitis Drug Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. Increasing incidence of atopic dermatitis, higher treatment compliance, growing prevalence of food allergies exacerbating atopic dermatitis, growing access to treatment in various developing countries and favorable reimbursement policies in some countries are driving the market growth
Respiratory Inhalers Market Comprehensive Analysis and Huge Growth Opportunity b …
Respiratory Inhalers Market - Pin-point Analysis of Market Dynamics The respiratory inhalers market is anticipated to grow in the forecast period owing to key factors such as increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD), reduced patient discomfort for inhalers, and technological advancements in respiratory inhaler devices. Moreover, regulatory approvals for new and advanced respiratory inhaler pose growing opportunities for the growth of the global respiratory inhalers market. Various market
More Releases for Gene
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Hemophilia Gene Therapy - A Pipeline Analysis Report
"The Report Hemophilia Gene Therapy - A Pipeline Analysis Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Hemophilia Gene Therapy: An insight Hemophilia is an inherited bleeding disorder. The gene responsible for hemophilia is present on the X chromosome and is inherited in a recessive manner. Hemophilia A, also called as factor VIII (FVIII) deficiency or classic hemophilia, is caused by missing
Gene Synthesis Market Size 2017-2022 OriGene, Gene Oracle, Genescript
e Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded
Gene Therapy Drug Pipeline Analysis
“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight
Cancer Gene Therapy Market Analysis
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant
Global Gene Synthesis Market Research Report 2017
Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded annual